2026-01-22 - Analysis Report
# Financial Report for JPMorgan Chase & Co (JKHY)

## 1. Return Rate Comparison
- **Cumulative Return (JKHY):** 20.86%
- **Cumulative Return (S&P 500, VOO):** 91.55%
- **Divergence:** -70.80%  
- **Relative Divergence:** 19.20%  

**Analysis:**  
JKHY has significantly underperformed compared to the S&P 500, with a divergence of -70.80%. The relative divergence indicates it is in the lower 19.20% of its historical performance range.

### Alpha, Beta Analysis

| Year       | CAGR  | MDD   | Alpha | Beta  | Cap(B) |
|------------|-------|-------|-------|-------|--------|
| 2016-2018  | 23.0% | 20.0% | 19.0% | 0.8   | 9.2    |
| 2017-2019  | 24.0% | 20.0% | 7.0%  | 0.8   | 10.6   |
| 2018-2020  | -11.0%| 21.6% | -32.0%| 0.8   | 11.8   |
| 2019-2021  | -11.0%| 21.6% | -55.0%| 0.8   | 12.1   |
| 2020-2022  | -9.0% | 21.6% | -8.0% | 0.7   | 12.8   |
| 2021-2023  | 4.0%  | 29.6% | 3.0%  | 0.7   | 11.9   |
| 2022-2024  | -3.0% | 29.6% | -22.0%| 0.7   | 12.7   |
| 2023-2025  | -7.0% | 21.8% | -69.0%| 0.5   | 13.3   |

**Analysis:**  
The data shows fluctuating performance in CAGR and MDD across different periods. The most recent periods (2023-2025) indicate a negative trend in both CAGR and Alpha, suggesting increasing risk and underperformance.

## 2. Recent Stock Price Fluctuations
- **Close Price:** $187.82
- **Previous Close:** $186.85
- **5-day SMA:** $189.77
- **20-day SMA:** $186.56
- **60-day SMA:** $175.33

**Analysis:**  
The stock shows a slight increase from the previous close, but the 5-day SMA indicates recent volatility above the current price, suggesting potential short-term fluctuations.

## 3. RSI and PPO Index Indicators
- **Market Risk Indicator (MRI):** 0.80 (Medium Investment)
- **RSI:** 55.31  
- **PPO:** -0.23  
- **Hybrid Signal:** Buy (Cash 0%)
- **Expected Return (%):** -123.20%

**Analysis:**  
The RSI indicates the stock is neither overbought nor oversold, while the negative PPO suggests underperformance relative to its moving averages. The expected return is significantly negative, indicating potential concerns for long-term investors.

## 4. Recent News & Significant Events
- **2026-01-21:** How to listen to Jack Henryâ€™s Q2 2026 earnings call live online (link)
- **2026-01-21:** Jack Henry & Associates to Provide Webcast of Second Quarter Fiscal 2026 Earnings Call (link)
- **2026-01-16:** Why Jack Henry (JKHY) is a Top Growth Stock for the Long-Term (link)
- **2026-01-14:** JKHY Stock Price, Forecast & Analysis (link)
- **2026-01-12:** JKHY Stock Surges 6.7% With A 6-day Winning Spree On Wolfe Research Upgrade to $220 (link)
- **2026-01-15:** Jack Henry (JKHY) is a Top-Ranked Momentum Stock: Should You Buy? (link)

**Analysis:**  
Recent news highlights a positive outlook and momentum for JKHY, particularly with a stock surge due to an upgrade.

## 4-2. Analyst Opinions
```text
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.12 (~Buy)
- Opinions: 14
- Target Price (avg/high/low): 196.36 / 220.00 / 164.00
```

## 5. Recent Earnings Analysis
| Date       | EPS  | Revenue |
|------------|------|---------|
| 2025-11-07 | 1.98 | 0.64 B$ |
| 2025-05-12 | 1.53 | 0.59 B$ |
| 2025-02-07 | 1.34 | 0.57 B$ |
| 2024-11-08 | 1.63 | 0.60 B$ |
| 2025-11-07 | 1.63 | 0.60 B$ |

**Analysis:**  
Earnings per share (EPS) shows a positive trend, peaking at 1.98 in the latest quarter. Revenue also shows growth, indicating improving operational performance.

## 6. Financial Information
### Revenue and Profitability
| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $0.64B | 45.94%        |
| 2025-06-30   | $0.62B | 44.12%        |
| 2025-03-31   | $0.59B | 41.79%        |
| 2024-12-31   | $0.57B | 42.00%        |
| 2024-09-30   | $0.60B | 42.85%        |

### Capital and Profitability
| Quarter      | Equity | ROE   |
|--------------|--------|-------|
| 2025-09-30   | $2.17B | 6.63% |
| 2025-06-30   | $2.13B | 5.99% |
| 2025-03-31   | $2.04B | 5.46% |
| 2024-12-31   | $1.98B | 4.95% |
| 2024-09-30   | $1.93B | 6.19% |

**Analysis:**  
Revenue growth is consistent, leading to improved profit margins. Equity is also increasing, though ROE shows slight fluctuations, indicating varying profitability relative to equity over time.

## 7. Comprehensive Analysis
JKHY shows significant underperformance relative to the S&P 500 with a divergence of -70.80%. Despite recent positive earnings and growth in revenue, the stock exhibits high volatility and a negative expected return over the long term. Analyst opinions remain cautiously optimistic with a consensus to buy, reflecting potential for recovery amidst current challenges.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.